The Immunological Basis for Treatment Resistance to Anti-TNF Treatments

NCT01971346 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Psoriasis

Interventions

DRUG: etanercept

Sponsor

University of Michigan

Collaborators

[object Object]